Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris

June 24, 2019 updated by: Laurent Bollag, University of Washington

The Effects of Intravenous Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris Device

This study evaluates effects of the analgesic ketamine on ANI measurements (Anti Nociceptive Index)

Study Overview

Status

Completed

Detailed Description

Researchers at the University of Washington are doing this study to find out if a commonly used anesthetic affects patients Analgesia Nociception Index (level of pain relief) during abdominal hysterectomy under general anesthesia.

The investigators will administer routine anesthesia care including Ketamine, a commonly used anesthetic, during the patients surgery. During the patients surgery, the investigators will monitor the patients level of pain relief using the PhysioDoloris monitor, which monitors the routinely used EKG monitor. Though not yet FDA approved, the PhysioDoloris is completely non-invasive and collects data from the EKG monitor.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98195
        • University of Washington

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women undergoing gynecological/abdominal surgery

Description

Inclusion Criteria:

  • ASA status I, II, or III
  • 18 years or older
  • Receiving GA with uncomplicated routine intubation
  • Ability to provide informed consent
  • English-speaking

Exclusion Criteria:

  • Presence of coronary artery disease, cardiac arrhythmias, or ketamine allergy
  • Patient refusal
  • History of substance abuse
  • Patients taking psychotropic and/or opiate drugs
  • Having a history of psychiatric diseases or psychological problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean ANI Changes After Intubation
Time Frame: Before vs after intubation
ANI stands for Analgesia Nociception Index. Its a dimension less number computed by a pain monitor ranging from 0-100. An index of 100 means absent pain, and the number decreases as pain increases. ANI was measured pre- and post- Intubation
Before vs after intubation
Mean ANI Changes 3 Min After Ketamine Bolus
Time Frame: Before vs 3 min after Ketamine adminstration
ANI was measured pre- and post- i.v. ketamine administration
Before vs 3 min after Ketamine adminstration
Mean ANI Changes 5 Min After Ketamine Bolus
Time Frame: Before vs 5 min after Ketamine adminstration
ANI was measured pre- and post- i.v. ketamine administration
Before vs 5 min after Ketamine adminstration
Mean ANI Changes After Skin Incision
Time Frame: Before vs after skin incision
ANI was measured pre- and post- skin incision
Before vs after skin incision

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean BIS Changes After Intubation
Time Frame: Before vs after intubation

BIS was measured pre- and post-intubation.

BIS, Bispectral index, is an indication of anesthesia depth and measured by a monitor during surgery (0-100 scale, range described below). Depth of sedation is calculated by measuring cerebral electric activity via an electroencephalogram (EEG).

  • 100-90: awake and responding appropriately to verbal stimulation
  • 80-70: responsive to loud commands or mild shaking
  • 60-40: unresponsive to verbal stimulus; general anesthesia obtained with a low chance for explicit recall
  • <40: deep hypnotic state; possible protective responses still intact
  • <20: burst suppression (EEG pattern characterized by cycles of high-voltage electrical movement alternating with cycles of no activity in the brain); respiratory drive is limited, but possible protective responses still intact
  • 0: totally suppressed EEG (flat line)
Before vs after intubation
Mean BIS Changes 3 Min After Ketamine Bolus
Time Frame: Before vs 3 min after Ketamine adminstration

BIS was measured pre- and post-Ketamine administration.

BIS, Bispectral index, is an indication of anesthesia depth and measured by a monitor during surgery (0-100 scale, range described below). Depth of sedation is calculated by measuring cerebral electric activity via an electroencephalogram (EEG).

  • 100-90: awake and responding appropriately to verbal stimulation
  • 80-70: responsive to loud commands or mild shaking
  • 60-40: unresponsive to verbal stimulus; general anesthesia obtained with a low chance for explicit recall
  • <40: deep hypnotic state; possible protective responses still intact
  • <20: burst suppression (EEG pattern characterized by cycles of high-voltage electrical movement alternating with cycles of no activity in the brain); respiratory drive is limited, but possible protective responses still intact
  • 0: totally suppressed EEG (flat line)
Before vs 3 min after Ketamine adminstration
Mean BIS Changes After Skin Incision
Time Frame: Before vs after skin incision

BIS was measured pre- and post-skin incision.

BIS, Bispectral index, is an indication of anesthesia depth and measured by a monitor during surgery (0-100 scale, range described below). Depth of sedation is calculated by measuring cerebral electric activity via an electroencephalogram (EEG).

  • 100-90: awake and responding appropriately to verbal stimulation
  • 80-70: responsive to loud commands or mild shaking
  • 60-40: unresponsive to verbal stimulus; general anesthesia obtained with a low chance for explicit recall
  • <40: deep hypnotic state; possible protective responses still intact
  • <20: burst suppression (EEG pattern characterized by cycles of high-voltage electrical movement alternating with cycles of no activity in the brain); respiratory drive is limited, but possible protective responses still intact
  • 0: totally suppressed EEG (flat line)
Before vs after skin incision
Mean Heart Rate Change After Intubation
Time Frame: Before vs after intubation
Heart rate assessed by continuous pulse oximetry. Heart rate was measured pre- and post-intubation.
Before vs after intubation
Mean Heart Rate Change 3 Min After Ketamine Bolus
Time Frame: Before vs 3 min after Ketamine adminstration
Heart rate was measured pre- and post- Ketamine administration
Before vs 3 min after Ketamine adminstration
Mean Heart Rate Change After Skin Incision
Time Frame: Before vs after skin incision
Heart rate was measured pre- and post-skin incision.
Before vs after skin incision
Change in Mean Arterial Pressure After Intubation
Time Frame: Before vs after intubation
MAP or mean arterial pressure is the average blood pressure of an individual and is measured non-invasively during surgery. MAP was measured pre- and post-intubation.
Before vs after intubation
Change in Mean Arterial Pressure After 3 Min After Ketamine Bolus
Time Frame: Before vs 3 min after Ketamine adminstration
MAP was measured pre- and post-ketamine administration
Before vs 3 min after Ketamine adminstration
Mean MAP Changes After Skin Incision
Time Frame: Before vs after skin incision
MAP was measured pre- and post- skin incision.
Before vs after skin incision

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average Ketamine Used
Time Frame: Surgery
Amount of Ketamine used during surgery
Surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laurent Bollag, MD, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

October 10, 2012

First Submitted That Met QC Criteria

October 25, 2012

First Posted (Estimate)

October 30, 2012

Study Record Updates

Last Update Posted (Actual)

August 5, 2019

Last Update Submitted That Met QC Criteria

June 24, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Monitoring, Intraoperative

3
Subscribe